Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
12.9M
-
Shares change
-
+4.22M
-
Total reported value, excl. options
-
$1.88M
-
Value change
-
+$591K
-
Put/Call ratio
-
0
-
Number of buys
-
10
-
Number of sells
-
-19
-
Price
-
$0.15
Significant Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) as of Q4 2023
49 filings reported holding GRTX - Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q4 2023.
Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.9M shares
of 75.5M outstanding shares and own 17.15% of the company stock.
Largest 10 shareholders include GSA CAPITAL PARTNERS LLP (3.89M shares), Sofinnova Investments, Inc. (3.08M shares), Blackstone Inc. (1.68M shares), abrdn plc (898K shares), Nan Fung Group Holdings Ltd (613K shares), CITADEL ADVISORS LLC (590K shares), VANGUARD GROUP INC (448K shares), GEODE CAPITAL MANAGEMENT, LLC (440K shares), BlackRock Inc. (358K shares), and RENAISSANCE TECHNOLOGIES LLC (314K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.